House Narrowly Passes Bill to Federally Criminalize Gender-Transition Treatments for Minors
In a closely divided vote reflecting the shifting legislative priorities of the 119th Congress, the U.S. House of Representatives on Wednesday narrowly passed a bill that would federally criminalize certain gender-transition treatments for minors. The legislation targets both surgical procedures and hormone therapies, proposing penalties of up to ten years in federal prison for healthcare providers found to be in violation.
The bill passed by a vote of 216–211, largely along party lines. While the measure represents a significant legislative victory for the conservative wing of the Republican majority and aligns closely with President Trump’s stated executive agenda, it faces substantial obstacles in the Senate, where passage would require bipartisan support that currently appears uncertain.
Legislative Strategy and Internal GOP Negotiations
The bill’s advancement to the House floor followed weeks of internal negotiations within the Republican caucus. Representative Marjorie Taylor Greene (R-GA) played a central role in pushing the legislation forward, reportedly using her leverage on unrelated defense policy votes to secure a commitment from Speaker Mike Johnson (R-LA) to schedule the measure.
Greene, who has announced plans to leave Congress before completing her current term, described the bill as an effort to codify executive actions into federal law. During floor debate, she argued that gender-transition treatments for minors constitute irreversible decisions that should not be permitted before adulthood.
“Most Americans agree that kids should be allowed to grow up before undergoing life-altering medical procedures,” Greene said, asserting that the 2024 election results reflected public support for stricter limits on such treatments. She used visual displays during the debate to emphasize her opposition to surgical interventions involving minors.
Deep Ideological Divisions on the House Floor
Debate over the bill highlighted stark ideological differences between Republicans and Democrats on healthcare policy, parental rights, and the role of government in private medical decisions. Supporters of the legislation framed it as a child-protection measure, with Representative Barry Moore (R-AL) describing gender-transition procedures as harmful and arguing that minors are not capable of providing informed consent for such treatments.
Democrats and civil rights advocates strongly opposed the bill, characterizing it as an unprecedented federal intrusion into family decision-making and medical practice. Representative Jamie Raskin (D-MD) questioned whether Congress should have the authority to override parents, physicians, and medical specialists in determining appropriate care for children.
Representative Mark Takano (D-CA) challenged the bill’s underlying premise, noting that the surgeries most often cited by supporters are statistically rare. He warned that the legislation could have broader consequences, including restricting access to commonly prescribed medications and potentially exposing sensitive medical information to federal oversight.
Representative Sarah McBride (D-DE), the first openly transgender member of Congress, criticized what she described as disproportionate legislative focus on transgender youth, a group she noted represents a small fraction of the population. McBride argued that the bill reflects an obsession that distracts from broader healthcare challenges facing American families.
Limited Bipartisan Defections
Despite the largely partisan nature of the vote, a small number of lawmakers crossed party lines. Democrats Henry Cuellar (TX), Vicente Gonzalez (TX), and Don Davis (NC) voted in favor of the bill. Meanwhile, Republicans Gabe Evans (CO), Brian Fitzpatrick (PA), Mike Lawler (NY), and Mike Kennedy (UT) voted against it, citing concerns ranging from federal overreach to medical autonomy.
What Comes Next
The legislative push against gender-affirming care for minors is expected to continue. Later this week, the House is scheduled to vote on a second bill, also backed by Greene, that would prohibit Medicaid from covering gender-transition procedures for minors.
As the primary bill moves to the Senate, its future remains uncertain. Senate leaders from both parties have signaled that the measure would face intense scrutiny, legal challenges, and potential filibuster hurdles. Even so, the House vote sends a clear signal about the current administration’s policy direction and the growing role of federal lawmakers in regulating healthcare decisions related to gender identity.
